JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB20841

Anti-Influenza A Virus 抗体

Anti-Influenza A Virus antibody

3

(1 Review)

|

(34 Publications)

Anti-Influenza A Virus antibody (ab20841) is a goat polyclonal antibody detecting Influenza A Virus in IHC-P, ICC/IF. Suitable for Influenza A.

- Over 20 publications
- Trusted since 2005
1 Images
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Influenza A Virus antibody (AB20841)
  • IHC-P

PubMed

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Influenza A Virus antibody (AB20841)

ab20841 staining Influenza A Virus in reconstructed 1918 H1N1 influenza infected Mouse lung tissue sections by Immunohistochemistry. Tissue was fixed with 10% neutral-buffered formalin and embedded in paraffin. Slides were deparaffinized, rehydrated in water, steam antigen retrieved in pH 6 citrate buffer, and blocked with 3% H2O2. Samples were incubated with primary antibody (1/500) for 1 hour at room temperature. Top - EUK-207 treated mouse, 8 days postinfection, Bottom uninfected mouse control. Brown staining indicates positive staining in cell's cytoplasm and/or nucleus. Cellular debris is also frequently positive.

Image from Kash JC et al., Free Radic Biol Med. 2013;67C:235-247. Fig 3.; doi: 10.1016/j.freeradbiomed.2013.10.014 with permission from Elsevier.

Key facts

宿主種

Goat

クローン性

Polyclonal

アイソタイプ

IgG

キャリアフリー

No

交差種

Influenza A

アプリケーション

ICC/IF, IHC-P

applications

免疫原

The exact immunogen used to generate this antibody is proprietary information.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Influenza A": { "IHCP-species-checked": "testedAndGuaranteed", "IHCP-species-dilution-info": "", "IHCP-species-notes": "<p>This product may be used in place of neat antiserum in almost any appropriate antibody-based technique.</p>", "ICCIF-species-checked": "guaranteed", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "<p></p>" } } }

製品の詳細

What is this antibody validated in?
Anti-Influenza A Virus antibody (ab20841) is a goat polyclonal antibody and is validated for use in Immunohistochemistry (IHC-P), Immunocytochemistry/immunofluorescence (ICC/IF) in Influenza A samples.

Trusted by the scientific community
Anti-Influenza A Virus (ab20841) was first used in a scientific publication in 2005 and has been cited over 20 times in peer-reviewed journals.

出荷温度及び保存条件

製品の状態
Liquid
精製方法
Ion exchange chromatography
精製に関する特記事項
>95% pure. Sodium sulfate precipitation and ion-exchange chromatography.
バッファー組成
Preservative: 0.1% Sodium azide Constituents: PBS
出荷温度
Blue Ice
短期保存温度
+4°C
長期保存温度
-20°C
分注に関する情報
Upon delivery aliquot
保管に関する情報
Avoid freeze / thaw cycle

補足情報

This supplementary information is collated from multiple sources and compiled automatically.

Influenza A virus also known as "flu A" is an important pathogen with a complex life cycle. Mechanically it consists of several proteins including hemagglutinin (HA) and neuraminidase (NA) which facilitate the virus's entry and release from host cells. The mass of the Influenza A virus is not a single value as it is a non-uniform entity composed of different proteins and RNA segments. This virus is mainly expressed in the epithelial cells of the respiratory tract in humans and other organisms. Through antigenic drift and shift the virus changes over time which makes it a significant challenge for public health.
Biological function summary

The Influenza A virus interferes with normal cellular functions. As it enters and replicates within host cells it triggers immune responses that seek to neutralize the virus a process often targeted by flu antibodies and anti-influenza therapies like arbidol 20 mg. The virus can hijack the host cell machinery to produce viral proteins and RNA forming complexes with cellular components to facilitate new virion assembly. This interaction often leads to the production of cytokines and can induce inflammation an important feature of infection by Influenza Type A.

Pathways

The Influenza A virus interacts with cellular pathways involved in endocytosis and RNA replication. It exploits the host cell's clathrin-mediated endocytosis for entry making use of the cellular machinery. In the context of RNA replication the virus's RNA-dependent RNA polymerase complex plays a critical role working alongside host cell proteins to synthesize viral RNA. The virus has well-documented interactions with proteins such as M1 matrix protein and NS1 non-structural protein which modulate both viral replication and interference with host immune responses.

Influenza A is a major cause of seasonal flu outbreaks and pandemics. It can lead to acute respiratory illness and is linked to life-threatening conditions like pneumonia. The virus often coexists in the respiratory system with other pathogens complicating the disease course. Proteins such as neuraminidase are important in its role in spreading the infection and represent targets for anti-flu therapies. The connection between Influenza A virus cytokine responses and severe respiratory conditions makes understanding its interaction with host proteins essential for developing effective treatments.

製品プロトコール

For this product, it's our understanding that no specific protocols are required. You can visit:

文献 (34)

Recent publications for all applications. Explore the full list and refine your search

Animals : an open access journal from MDPI 15: PubMed40723520

2025

Clade 2.3.4.4b Highly Pathogenic Avian Influenza H5N1 Pathology in a Common Shorebird Species (Sanderling; ) in Virginia, USA.

Applications

Unspecified application

Species

Unspecified reactive species

Victoria A Andreasen,Emily G Phillips,Aidan M O'Reilly,C Robert Stilz,Rebecca L Poulson,Ruth Boettcher,John K Tracey,Nicole M Nemeth

Viruses 17: PubMed40284987

2025

Construction and Immune Strategy Optimization of a Vaccine Strain for Influenza A (H5N8) Subtype.

Applications

Unspecified application

Species

Unspecified reactive species

Shuxia Zhang,Jing Tang,Liqi Liu,Hejiang Wei,Li Xin,Kang Xiao,Jinbo Xiao,Jie Dong,Zi Li,Hongyan Bai,Shuaixing Wang,Wenfei Zhu,Lei Yang,Shumei Zou,Dayan Wang

Vaccines 13: PubMed39852860

2025

The Development of a Novel Broad-Spectrum Influenza Polypeptide Vaccine Based on Multi-Epitope Tandem Sequences.

Applications

Unspecified application

Species

Unspecified reactive species

Song Zhao,Junhao Luo,Wenhui Guo,Li Li,Siyu Pu,Libo Dong,Wenfei Zhu,Rongbao Gao

Animals : an open access journal from MDPI 14: PubMed39765604

2025

Surveillance of Highly Pathogenic Avian Influenza Virus in Wild Canids from Pennsylvania, USA.

Applications

Unspecified application

Species

Unspecified reactive species

Kevin D Niedringhaus,Taylor C Chan,Ashley McDowell,Lauren Maxwell,Madison Stevens,Lane Potts,Erica Miller,Eman Anis,Kyle Van Why,Thomas Keller,David Stallknecht,Rebecca L Poulson,Kaitlyn Bahrs,Justin D Brown

Science advances 10:eads5735 PubMed39671482

2024

Effect of pandemic influenza A virus PB1 genes of avian origin on viral RNA polymerase activity and pathogenicity.

Applications

Unspecified application

Species

Unspecified reactive species

Stephanie L Williams,Li Qi,Zong-Mei Sheng,Yongli Xiao,Ashley Freeman,Lex Matthews,Sharon Fong Legaspi,Ervin Fodor,Jeffery K Taubenberger

PLoS pathogens 20:e1012345 PubMed38968329

2024

mRNA-encoded Cas13 treatment of Influenza via site-specific degradation of genomic RNA.

Applications

Unspecified application

Species

Unspecified reactive species

Lorena C S Chaves,Nichole Orr-Burks,Daryll Vanover,Varun V Mosur,Sarah R Hosking,Pramod Kumar E K,Hyeyoon Jeong,Younghun Jung,José A F Assumpção,Hannah E Peck,Sarah L Nelson,Kaitlyn N Burke,McKinzie A Garrison,Robert A Arthur,Henry Claussen,Nicholas S Heaton,Eric R Lafontaine,Robert J Hogan,Chiara Zurla,Philip J Santangelo

Emerging microbes & infections 13:2373314 PubMed38922326

2024

R229I substitution from oseltamivir induction in HA1 region significantly increased the fitness of a H7N9 virus bearing NA 292K.

Applications

Unspecified application

Species

Unspecified reactive species

Jing Tang,Shu-Mei Zou,Jian-Fang Zhou,Rong-Bao Gao,Li Xin,Xiao-Xu Zeng,Wei-Juan Huang,Xi-Yan Li,Yan-Hui Cheng,Li-Qi Liu,Ning Xiao,Da-Yan Wang

Journal of virology 98:e0190123 PubMed38629840

2024

Influenza A virus NS1 effector domain is required for PA-X-mediated host shutoff in infected cells.

Applications

Unspecified application

Species

Unspecified reactive species

Juliette Bougon,Eileigh Kadijk,Lucie Gallot-Lavallee,Bruce A Curtis,Matthew Landers,John M Archibald,Denys A Khaperskyy

Infectious medicine 3:100090 PubMed38444745

2024

Rapid adaptive substitution of L226Q in HA protein increases the pathogenicity of H9N2 viruses in mice.

Applications

Unspecified application

Species

Unspecified reactive species

Min Tan,Ye Zhang,Hong Bo,Xiyan Li,Shumei Zou,Lei Yang,Jia Liu,Qi Chen,Xiaohao Xu,Wenfei Zhu,Dayan Wang

Journal of virology 96:e0134122 PubMed36326278

2022

Respiratory Syncytial Virus Protects Bystander Cells against Influenza A Virus Infection by Triggering Secretion of Type I and Type III Interferons.

Applications

Unspecified application

Species

Unspecified reactive species

Maciej Czerkies,Marek Kochańczyk,Zbigniew Korwek,Wiktor Prus,Tomasz Lipniacki
View all publications

Abcam product promise

当社は、高品質な試薬を通じてお客様の研究を力強くサポートすることをお約束いたします。ご使用いただく各段階で、常にお客様をサポートできる体制を整えております。万が一、製品が期待通りに機能しない場合は、「Abcam Product Promise」による当社保証制度に基づき、安心してご利用いただけます。
保証に関する詳細については利用規約をご確認ください。

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com